FDCDDQ
PTLA

Federation des caisses Desjardins du Quebec’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-225
Closed -$5.99K – 2171
2018
Q3 		$5.99K Sell
225
-450
-67% -$14.7K ﹤0.01% 1840
2018
Q2 		$25.5K Buy
+675
New +$25.8K ﹤0.01% 1517

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's PTLA Position: Q4 2018 in Review

Federation des caisses Desjardins du Quebec sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2018, closing a stake of 225 shares — an estimated $5.99K sold.

Federation des caisses Desjardins du Quebec first reported a position in PTLA in Q2 2018 and held it in 2 quarters. The position peaked at $25.5K in Q2 2018. 181 funds tracked by Wall St. Rank hold PTLA as of Q4 2018.

  • Federation des caisses Desjardins du Quebec reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 225 Portola Pharmaceuticals, Inc. shares in Q4 2018, an estimated $5.99K.
  • Federation des caisses Desjardins du Quebec first reported a position in Portola Pharmaceuticals, Inc. in Q2 2018 and held it in 2 quarters.
  • Federation des caisses Desjardins du Quebec's Portola Pharmaceuticals, Inc. position peaked at $25.5K in Q2 2018.
  • 181 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2018.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2018, filed 30 Aug 2024.